Yihong Yang, Ph.D.
National Institute on Drug Abuse (NIDA)
4
4
0
N/A
0
14
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Elliot Stein, Ph.D.
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Worked with same sponsors:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
Pablo Tebas, MD
University of Pennsylvania
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Senior Manager
Takeda
Shared therapeutic areas:
Lorenzo Berra, MD
Massachusetts General Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Mechanism of Non-invasive Magnetic Stimulation
Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)
All 4 trials loaded